260 related articles for article (PubMed ID: 27960558)
21. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells.
Duchartre Y; Kim YM; Kahn M
Methods Mol Biol; 2017; 1613():463-478. PubMed ID: 28849572
[TBL] [Abstract][Full Text] [Related]
22. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation.
Vallée A; Vallée JN; Lecarpentier Y
Aging (Albany NY); 2021 Apr; 13(7):10796-10813. PubMed ID: 33848261
[TBL] [Abstract][Full Text] [Related]
23. Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials.
Neiheisel A; Kaur M; Ma N; Havard P; Shenoy AK
Int J Cancer; 2022 Mar; 150(5):727-740. PubMed ID: 34536299
[TBL] [Abstract][Full Text] [Related]
24. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Neuromolecular Med; 2018 Jun; 20(2):174-204. PubMed ID: 29572723
[TBL] [Abstract][Full Text] [Related]
25. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
[TBL] [Abstract][Full Text] [Related]
26. Notch and Wnt signaling pathway in cancer: Crucial role and potential therapeutic targets (Review).
Xiao YF; Yong X; Tang B; Qin Y; Zhang JW; Zhang D; Xie R; Yang SM
Int J Oncol; 2016 Feb; 48(2):437-49. PubMed ID: 26648421
[TBL] [Abstract][Full Text] [Related]
27. The role of Wnt signaling in neuroprotection.
Cerpa W; Toledo EM; Varela-Nallar L; Inestrosa NC
Drug News Perspect; 2009 Dec; 22(10):579-91. PubMed ID: 20140278
[TBL] [Abstract][Full Text] [Related]
28. Treatments and compositions targeting α-synuclein: a patent review (2010-2016).
Jęśko H; Lenkiewicz AM; Adamczyk A
Expert Opin Ther Pat; 2017 Apr; 27(4):427-438. PubMed ID: 27841042
[TBL] [Abstract][Full Text] [Related]
29. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract][Full Text] [Related]
30. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
[TBL] [Abstract][Full Text] [Related]
31. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
Dahmani R; Just PA; Perret C
Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
[TBL] [Abstract][Full Text] [Related]
32. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
33. Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders.
Al-Harthi L
J Neuroimmune Pharmacol; 2012 Dec; 7(4):725-30. PubMed ID: 23114888
[TBL] [Abstract][Full Text] [Related]
34. Wnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights.
Xue G; Romano E; Massi D; Mandalà M
Cancer Treat Rev; 2016 Sep; 49():1-12. PubMed ID: 27395773
[TBL] [Abstract][Full Text] [Related]
35. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.
Nusse R; Clevers H
Cell; 2017 Jun; 169(6):985-999. PubMed ID: 28575679
[TBL] [Abstract][Full Text] [Related]
36. Rational drug discovery design approaches for treating Parkinson's disease.
Van der Schyf CJ
Expert Opin Drug Discov; 2015 Jul; 10(7):713-41. PubMed ID: 26054694
[TBL] [Abstract][Full Text] [Related]
37. Wnt Signaling and Drug Resistance in Cancer.
Zhong Z; Virshup DM
Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
[TBL] [Abstract][Full Text] [Related]
39. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.
Driehuis E; Clevers H
Br J Pharmacol; 2017 Dec; 174(24):4547-4563. PubMed ID: 28244067
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.
Tabatabai R; Linhares Y; Bolos D; Mita M; Mita A
Target Oncol; 2017 Oct; 12(5):623-641. PubMed ID: 28653295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
